Product Code: ETC340870 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The polio vaccine market in France involves the production, distribution, and administration of vaccines aimed at preventing poliomyelitis, a highly contagious viral disease caused by poliovirus infection, which can lead to paralysis and even death in severe cases. Polio vaccines stimulate the immune system to produce antibodies against the poliovirus, providing immunity and preventing infection and transmission of the disease. In France, polio vaccination programs are conducted as part of routine childhood immunization schedules, typically administering inactivated polio vaccine (IPV) or oral polio vaccine (OPV) to infants and young children to ensure population immunity and eradicate poliovirus transmission. With a focus on public health, disease eradication, and global vaccination initiatives such as the Global Polio Eradication Initiative (GPEI), stakeholders in the polio vaccine market in France collaborate with healthcare authorities, international organizations, and vaccine manufacturers to ensure vaccine availability, maintain high vaccination coverage rates, and support polio eradication efforts worldwide.
In France, the polio vaccine market experiences growth driven by global eradication efforts, vaccination campaigns, and public health initiatives. Polio vaccines play a critical role in preventing poliomyelitis, a highly contagious viral disease that can cause paralysis and death. Market expansion is propelled by factors such as international partnerships to eradicate polio, government funding for vaccination programs, and the introduction of new vaccine formulations. Additionally, advancements in vaccine technology, production scalability, and efforts to address vaccine hesitancy contribute to market development.
The France polio vaccine market faces challenges related to vaccine coverage and eradication efforts. While polio vaccination has been successful in reducing cases globally, challenges remain in reaching remote and underserved populations. Moreover, addressing vaccine-derived polio outbreaks and maintaining high vaccination coverage to prevent polio resurgence pose ongoing challenges for public health authorities and vaccine manufacturers in this market.
France implements vaccination programs to eradicate polio and protect public health. Government policies focus on vaccination coverage, immunization campaigns, and disease surveillance to ensure access to polio vaccines and prevent outbreaks of polio in the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Polio Vaccine Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Polio Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 France Polio Vaccine Market - Industry Life Cycle |
3.4 France Polio Vaccine Market - Porter's Five Forces |
3.5 France Polio Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 France Polio Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 France Polio Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases like polio |
4.2.2 Government initiatives to promote immunization and eradicate polio |
4.2.3 Technological advancements in vaccine development and production |
4.3 Market Restraints |
4.3.1 Vaccine supply chain challenges such as storage and distribution requirements |
4.3.2 Vaccine hesitancy among certain segments of the population |
4.3.3 Regulatory hurdles and compliance issues in vaccine approval processes |
5 France Polio Vaccine Market Trends |
6 France Polio Vaccine Market, By Types |
6.1 France Polio Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 France Polio Vaccine Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 France Polio Vaccine Market Revenues & Volume, By Oral Polio Vaccine (OPV), 2021-2031F |
6.1.4 France Polio Vaccine Market Revenues & Volume, By Inactivated Poliomyelitis Vaccine (IPV), 2021-2031F |
6.2 France Polio Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Polio Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.2.3 France Polio Vaccine Market Revenues & Volume, By Private, 2021-2031F |
7 France Polio Vaccine Market Import-Export Trade Statistics |
7.1 France Polio Vaccine Market Export to Major Countries |
7.2 France Polio Vaccine Market Imports from Major Countries |
8 France Polio Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rates among children in France |
8.2 Number of polio cases reported in France |
8.3 Research and development investments in new polio vaccine technologies |
8.4 Public perception and acceptance of vaccination through surveys or focus groups |
8.5 Adverse events following immunization (AEFI) reporting rates |
9 France Polio Vaccine Market - Opportunity Assessment |
9.1 France Polio Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 France Polio Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 France Polio Vaccine Market - Competitive Landscape |
10.1 France Polio Vaccine Market Revenue Share, By Companies, 2024 |
10.2 France Polio Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |